Search
Xilio Therapeutics Inc
XLOAdd to Watchlist
8.940USD
-0.100-1.11%
Close 09-23 16:00（ET）
53.46MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-1.11%
5 Days
-0.45%
1 Month
-3.14%
6 Months
+13.74%
Year to Date
-0.22%
1 Year
-17.28%
Key Figures
9.030Open
9.040High
235.00Volume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.00%Turnover Ratio
9.040Prev. Close
8.940Low
2.12KTurnover
LossP/E Static
0.75P/B
0.00%Div Yield TTM
-23.43%ROA
9.90052wk High
0.52Volume Ratio
-58.24MNet Profit
5.98MShares
-56.7568EPS TTM
-0.10Beta
-75.20%ROE
6.46852wk Low
2.32%Amplitude
100.00%Gross Margin
53.46MMarket Cap
2.22Reward/Risk
88.72%Risk Rate
More news coming soon, stay tuned...
Xilio Therapeutics Inc's Score
-0.05vs previous score
Forecast10.00
Financial Health9.20
Technical3.15
Valuation Dimensions8.90
Institutional Confidence5.00
Risk Assessment4.17
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Xilio Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.33/-0.59
Revenue / Forecast
18.69M/12.72M
Xilio Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolXLO
Number of employees64
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Gilead Sciences, Inc | 10.87% |
| GKCC, LLC | 8.36% |
| Frazier Life Sciences Management, L.P. | 7.06% |
| AbbVie, Inc. | 5.19% |
| Shareholder Types | Proportion |
|---|---|
| Corporation | 27.95% |
| Hedge Fund | 15.11% |
| Investment Advisor | 9.64% |
| Private Equity | 7.06% |
Related Instruments
-1.64%
-0.01%
-0.05%
-1.88%
+1.01%
-2.99%
-1.01%
-0.85%
-3.12%
+0.90%
+0.26%
-1.77%
-1.20%
-2.00%
-1.99%
-0.26%
-0.25%
-0.74%
-1.86%
-0.35%Popular Instruments
51263.700
-226.300 (-0.44%)
30185.200
-292.700 (-0.96%)
7660.700
-46.300 (-0.60%)
14263.000
-159.000 (-1.10%)
65365.000
-764.000 (-1.16%)
6255.400
-34.600 (-0.55%)
94.123
+1.633 (+1.77%)
337.020
-2.730 (-0.80%)
225.510
-3.360 (-1.47%)
4267.990
-18.250 (-0.43%)
FAQs
What is the current price of Xilio Therapeutics Inc (XLO)?
The current price of Xilio Therapeutics Inc (XLO) is 8.94.
What is the symbol of Xilio Therapeutics Inc?
The ticker symbol of Xilio Therapeutics Inc is XLO.
What is the 52-week high of Xilio Therapeutics Inc?
The 52-week high of Xilio Therapeutics Inc is 9.90.
What is the 52-week low of Xilio Therapeutics Inc?
The 52-week low of Xilio Therapeutics Inc is 6.47.
What is the market capitalization of Xilio Therapeutics Inc?
The market capitalization of Xilio Therapeutics Inc is 53.46M.
Is Xilio Therapeutics Inc (XLO) currently rated as Buy, Hold, or Sell?
According to analysts, Xilio Therapeutics Inc (XLO) has an overall rating of STRONG BUY, with a price target of 20.00.
What is the Earnings Per Share (EPS TTM) of Xilio Therapeutics Inc (XLO)?
The Earnings Per Share (EPS TTM) of Xilio Therapeutics Inc (XLO) is -56.76.